MicroRNAs
6
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Circulating microRNAs and Response to Neoadjuvant Chemotherapy in Breast Cancer
Search for Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAs
Dynamics of microRNA Expression and Systemic Inflammatory Response in POCD After Cardiac Surgery
Serum MicroRNAs as Diagnostic Biomarkers of Colorectal Cancer
Study on the Relationship Between Peripheral Blood miRNA and Risk and Severity of Alzheimer's Disease
MicroRNAs From Blood Samples as Biomarkers for Gastric Cancer Detection